CMPX - CIK 0001738021
The table below shows Compass Therapeutics, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $30.64M | $43.48M | $24.23M | $34.95M | $144.51M | $47.08M |
| Short-term investments | $178.26M | $83.24M | $128.23M | $151.66M | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $209.82M |
| $132.75M |
| $153.88M |
| $194.79M |
| $147.10M |
| $50.20M |
| Property, plant & equipment | $102.00K | $353.00K | $898.00K | $1.57M | $2.24M | $1.13M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $219.59M | $140.40M | $156.88M | $199.65M | $153.76M | $51.91M |
| Accounts payable | $1.58M | $2.25M | $4.09M | $3.38M | $867.00K | $1.06M |
| Total current liabilities | $13.97M | $8.87M | $7.80M | $16.17M | $10.63M | $10.10M |
| Long-term debt | - | - | - | - | $0.00 | $1.87M |
| Total liabilities | $22.80M | $15.17M | $8.34M | $18.01M | $13.68M | $11.97M |
| Retained earnings | -$431.17M | -$364.68M | -$315.31M | -$272.81M | -$233.59M | -$151.41M |
| Total equity | $196.79M | $125.23M | $148.54M | $181.64M | $140.08M | $39.95M |